TOP STORIES
dermatology
Dermatitis

Relief at last: dupilumab on the PBS for atopic dermatitis


Dupilumab (Dupixent) has been listed on the PBS from March 1 for the treatment of adolescent and adult patients with severe atopic dermatitis that has not responded to topical therapies. The long awaited listing of the monoclonal antibody comes after three...

Dupilumab (Dupixent) has been listed on the PBS from March 1 for the treatment of adolescent and adult patients with...

Read more